Exelixis, Inc. - stock earnings
EXEL Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 AfterMarket | 0.17 / 0.24 | - | 425.2 million / 464.6 million | - |
| July 30, 2024 BeforeMarket | - / - | 432.0 million | - / 468.9 million | 547.0 million |
EXEL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 37.3 million USD | 425.2 million USD |
| 2023Q4 | 85.5 million USD | 479.7 million USD |
| 2023Q3 | 1.0 million USD | 471.9 million USD |
| 2023Q2 | 81.2 million USD | 469.8 million USD |
| 2023Q1 | 40.0 million USD | 408.8 million USD |
| 2022Q4 | -30.2 million USD | 423.9 million USD |
| 2022Q3 | 73.2 million USD | 411.7 million USD |
| 2022Q2 | 70.7 million USD | 419.4 million USD |
| 2022Q1 | 68.6 million USD | 356.0 million USD |
| 2021Q4 | 95.2 million USD | 451.1 million USD |
| 2021Q3 | 38.2 million USD | 328.4 million USD |
| 2021Q2 | 96.1 million USD | 385.2 million USD |
| 2021Q1 | 1.6 million USD | 270.2 million USD |
| 2020Q4 | 28.4 million USD | 270.1 million USD |
| 2020Q3 | -32.0 million USD | 231.1 million USD |
| 2020Q2 | 66.8 million USD | 259.5 million USD |
| 2020Q1 | 48.6 million USD | 226.9 million USD |
| 2019Q4 | 68.7 million USD | 240.3 million USD |
| 2019Q3 | 97.5 million USD | 271.7 million USD |
| 2019Q2 | 79.0 million USD | 240.3 million USD |
| 2019Q1 | 75.8 million USD | 215.5 million USD |
| 2018Q4 | 360.1 million USD | 228.6 million USD |
| 2018Q3 | 126.6 million USD | 225.4 million USD |
| 2018Q2 | 87.5 million USD | 186.1 million USD |
| 2018Q1 | 115.9 million USD | 212.3 million USD |
| 2017Q4 | 38.5 million USD | 120.1 million USD |
| 2017Q3 | 81.4 million USD | 152.5 million USD |
| 2017Q2 | 17.7 million USD | 99.0 million USD |
| 2017Q1 | 16.7 million USD | 80.9 million USD |
| 2016Q4 | 35.1 million USD | 77.6 million USD |
| 2016Q3 | -11.3 million USD | 62.2 million USD |
| 2016Q2 | -37.0 million USD | 36.3 million USD |
| 2016Q1 | -61.3 million USD | 15.4 million USD |
| 2015Q4 | -43.6 million USD | 9.9 million USD |
| 2015Q3 | -47.6 million USD | 9.9 million USD |
| 2015Q2 | -43.4 million USD | 8.0 million USD |
| 2015Q1 | -35.2 million USD | 9.4 million USD |
| 2014Q4 | -58.0 million USD | 7.4 million USD |
| 2014Q3 | -62.6 million USD | 6.3 million USD |
| 2014Q2 | -73.4 million USD | 6.6 million USD |
| 2014Q1 | -74.6 million USD | 4.9 million USD |
| 2013Q4 | -70.7 million USD | 4.3 million USD |
| 2013Q3 | -67.1 million USD | 5.5 million USD |
| 2013Q2 | -62.2 million USD | 11.9 million USD |
| 2013Q1 | -44.7 million USD | 9.7 million USD |
| 2012Q4 | -52.2 million USD | 7.8 million USD |
| 2012Q3 | -32.8 million USD | 13.3 million USD |
| 2012Q2 | -36.5 million USD | 7.8 million USD |
| 2012Q1 | -26.2 million USD | 18.5 million USD |
| 2011Q4 | 46.3 million USD | 93.3 million USD |
| 2011Q3 | 77.9 million USD | 128.3 million USD |
| 2011Q2 | -21.0 million USD | 32.2 million USD |
| 2011Q1 | -27.5 million USD | 35.9 million USD |
| 2010Q4 | -17.9 million USD | 40.8 million USD |
| 2010Q3 | -8.6 million USD | 54.5 million USD |
| 2010Q2 | -22.6 million USD | 47.6 million USD |
| 2010Q1 | -43.2 million USD | 42.2 million USD |
| 2009Q4 | -28.8 million USD | 44.1 million USD |
| 2009Q3 | -25.4 million USD | 55.0 million USD |
| 2009Q2 | -44.8 million USD | 27.4 million USD |
| 2009Q1 | -36.2 million USD | 25.3 million USD |
| 2008Q4 | -37.9 million USD | 29.6 million USD |
| 2008Q3 | -38.5 million USD | 29.9 million USD |
| 2008Q2 | -45.1 million USD | 30.4 million USD |
| 2008Q1 | -41.3 million USD | 27.9 million USD |
| 2007Q4 | -19.9 million USD | 29.3 million USD |
| 2007Q3 | -13.7 million USD | 26.8 million USD |
| 2007Q2 | -28.6 million USD | 29.3 million USD |
| 2007Q1 | -24.2 million USD | 28.1 million USD |
| 2006Q4 | -25.2 million USD | 29.8 million USD |
| 2006Q3 | -25.2 million USD | 23.5 million USD |
| 2006Q2 | -24.0 million USD | 27.2 million USD |
| 2006Q1 | -27.1 million USD | 18.1 million USD |
| 2005Q4 | -24.5 million USD | 14.4 million USD |
| 2005Q3 | -22.8 million USD | 14.4 million USD |
| 2005Q2 | -9.7 million USD | 34.3 million USD |
| 2005Q1 | -27.4 million USD | 12.9 million USD |
| 2004Q4 | -51.9 million USD | 15.7 million USD |
| 2004Q3 | -27.2 million USD | 12.7 million USD |
| 2004Q2 | -29.3 million USD | 12.6 million USD |
| 2004Q1 | -28.8 million USD | 11.9 million USD |
| 2003Q4 | -23.3 million USD | 13.8 million USD |
| 2003Q3 | -25.0 million USD | 12.4 million USD |
| 2003Q2 | -23.4 million USD | 13.0 million USD |
| 2003Q1 | -23.1 million USD | 12.3 million USD |
| 2002Q4 | -20.9 million USD | 12.5 million USD |
| 2002Q3 | -22.9 million USD | 10.4 million USD |
| 2002Q2 | -23.9 million USD | 9.9 million USD |
| 2002Q1 | -18.4 million USD | 11.6 million USD |
| 2001Q4 | -18.3 million USD | 12.8 million USD |
| 2001Q3 | -16.5 million USD | 11.9 million USD |
| 2001Q2 | -12.7 million USD | 7.7 million USD |
| 2001Q1 | -12.7 million USD | 7.7 million USD |
| 2000Q4 | -48.1 million USD | 7.1 million USD |
| 2000Q3 | -9.0 million USD | 6.1 million USD |
| 2000Q2 | -11.0 million USD | 5.6 million USD |
| 2000Q1 | -7.3 million USD | 6.0 million USD |
| 1999Q4 | -7.3 million USD | 6.0 million USD |
EXEL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 207.8 million USD | 1.8 billion USD |
| 2022 | 182.3 million USD | 1.6 billion USD |
| 2021 | 231.1 million USD | 1.4 billion USD |
| 2020 | 111.8 million USD | 987.5 million USD |
| 2019 | 321.0 million USD | 967.8 million USD |
| 2018 | 690.1 million USD | 853.8 million USD |
| 2017 | 154.2 million USD | 452.5 million USD |
| 2016 | -70.2 million USD | 191.5 million USD |
| 2015 | -169.7 million USD | 37.2 million USD |
| 2014 | -268.5 million USD | 25.1 million USD |
| 2013 | -244.8 million USD | 31.3 million USD |
| 2012 | -147.6 million USD | 47.5 million USD |
| 2011 | 75.7 million USD | 289.6 million USD |
| 2010 | -92.3 million USD | 185.0 million USD |
| 2009 | -135.2 million USD | 151.8 million USD |
| 2008 | -162.9 million USD | 117.9 million USD |
| 2007 | -86.4 million USD | 113.5 million USD |
| 2006 | -101.5 million USD | 98.7 million USD |
| 2005 | -84.4 million USD | 76.0 million USD |
| 2004 | -137.2 million USD | 52.9 million USD |
| 2003 | -94.8 million USD | 51.5 million USD |
| 2002 | -86.1 million USD | 44.3 million USD |
| 2001 | -71.2 million USD | 41.0 million USD |
| 2000 | -75.3 million USD | 24.8 million USD |
| 1999 | -18.7 million USD | 10.5 million USD |
| 1998 | -15.7 million USD | 2.3 million USD |
EXEL
Price: $21.90
52 week price:
Earnings Per Share: 0.65 USD
P/E Ratio: 31.11
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 986798
Ebitda: 84.9 millionMarket Capitalization: 6.4 billion